Literature DB >> 16411511

STEP: an intervention to address the issue of stigma related to leprosy in Southern Nepal.

Hugh Cross1, Ramesh Choudhary.   

Abstract

This paper focuses primarily on the extent to which a Stigma Elimination Programme (STEP) affected the social participation of people affected by leprosy in southern Nepal. The Participation Scale (popularly known as The P Scale) was applied to compare leprosy affected people who participated in STEP groups with a control group comprising leprosy affected people who lived in villages where STEP had not been implemented. It was found that STEP participants had significantly higher levels of participation compared with controls and that their levels of social participation were higher than would be expected even for the general population. It was also found that leprosy affected people without visible deformity or ulceration (whether in the STEP group or not) do not appear to suffer participation restriction in southern Nepal.

Entities:  

Mesh:

Year:  2005        PMID: 16411511

Source DB:  PubMed          Journal:  Lepr Rev        ISSN: 0305-7518            Impact factor:   0.537


  22 in total

1.  Evaluation of a health setting-based stigma intervention in five African countries.

Authors:  Leana Uys; Maureen Chirwa; Thecla Kohi; Minrie Greeff; Joanne Naidoo; Lucia Makoae; Priscilla Dlamini; Kevin Durrheim; Yvette Cuca; William L Holzemer
Journal:  AIDS Patient Care STDS       Date:  2009-12       Impact factor: 5.078

2.  Peer support groups as an intervention to decrease epilepsy-associated stigma.

Authors:  Melissa A Elafros; Julius Mulenga; Edward Mbewe; Alan Haworth; Elwyn Chomba; Masharip Atadzhanov; Gretchen L Birbeck
Journal:  Epilepsy Behav       Date:  2013-03-01       Impact factor: 2.937

3.  The development of a capacity-strengthening program to promote self-care practices among people with lymphatic filariasis-related lymphedema in the Upper West Region of Ghana.

Authors:  Solomon Abotiba Atinbire; Benjamin Marfo; Bright Alomatu; Collins Ahorlu; Paul Saunderson; Stefanie Weiland
Journal:  Infect Dis Poverty       Date:  2021-05-07       Impact factor: 4.520

Review 4.  Interventions for ulceration and other skin changes caused by nerve damage in leprosy.

Authors:  Liv Merete Reinar; Louise Forsetlund; Linda Faye Lehman; Kjetil G Brurberg
Journal:  Cochrane Database Syst Rev       Date:  2019-07-31

5.  Dealing with stigma: experiences of persons affected by disabilities and leprosy.

Authors:  Mimi Lusli; Marjolein B M Zweekhorst; Beatriz Miranda-Galarza; Ruth M H Peters; Sarah Cummings; Francisia S S E Seda; Joske F G Bunders
Journal:  Biomed Res Int       Date:  2015-04-15       Impact factor: 3.411

6.  Health-related quality of life, depression, and self-esteem in adolescents with leprosy-affected parents: results of a cross-sectional study in Nepal.

Authors:  Nobuko Yamaguchi; Krishna C Poudel; Masamine Jimba
Journal:  BMC Public Health       Date:  2013-01-10       Impact factor: 3.295

7.  The meaning of leprosy and everyday experiences: an exploration in cirebon, indonesia.

Authors:  Ruth M H Peters; Mimi Lusli; Beatriz Miranda-Galarza; Wim H van Brakel; Marjolein B M Zweekhorst; Rita Damayanti; Francisia S S E Seda; Joske F G Bunders
Journal:  J Trop Med       Date:  2013-03-20

Review 8.  Cost-effectiveness of interventions to prevent disability in leprosy: a systematic review.

Authors:  Natasja H J van Veen; Paul McNamee; Jan Hendrik Richardus; W Cairns S Smith
Journal:  PLoS One       Date:  2009-02-20       Impact factor: 3.240

9.  Social participation of diabetes and ex-leprosy patients in the Netherlands and patient preference for combined self-care groups.

Authors:  Henry J C de Vries; Roos de Groot; Wim H van Brakel
Journal:  Front Med (Lausanne)       Date:  2014-08-18

10.  The Impact of Leprosy on Marital Relationships and Sexual Health among Married Women in Eastern Nepal.

Authors:  Anna T van 't Noordende; Wim H van Brakel; Nandlal Banstola; Krishna P Dhakal
Journal:  J Trop Med       Date:  2016-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.